Skip to content

Mitral leaflet adaptation in ischemic functional regurgitation: A prospective clinical study using real-time 3-dimensional echocardiography

Mitral leaflet adaptation in ischemic functional regurgitation: A prospective clinical study using real-time 3-dimensional echocardiography

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-13003951
Enrollment
Unknown
Registered
2013-12-02
Start date
2013-02-18
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic mitral regurgitation post first episode of myocardial infarction

Interventions

ischemic MR:NA
non-ischemic MR:NA
control:NA

Sponsors

Research Grant Council
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Prospectively enrolled patients hospitalized for first episode of acute MI. 1. Diagnosis of MI is based on cardiac pain, newly developed Q waves, ST elevation/depression on ECG, and typical rise and fall of cardiac biomarkers (Troponin and/or CPK); 2. Patient will receive standard management for acute MI including medications and/or revascularization according to physician discretion; 3. All MI patients meeting the inclusion criteria will have serial transthoracic echocardiographic study including 2D/3D/TDI within 72 hours, in 7-14 days, and at 1 month post-MI. Patients will be separated into 2 groups based on presence or absence of IMR at 1 month, as defined by color flow imaging. The rationale of using 1 month for group separation is to avoid inclusion of transient MR due to acute ischemia, and is based on accepted definition of IMR in large epidemiological studies (2-4), as well as the time frame of ML adaptation in animal studies (13, 14, 17); 4. Healthy controls with normal history, physical examination and echocardiography matched for age, gender and body surface area will be enrolled from the community.

Exclusion criteria

Exclusion criteria: Prior MI or known left ventricular dysfunction, previous cardiac surgery, papillary muscle rupture, MR due to primary organic valve disease, associated aortic valve or congenital heart disease, poor image quality, and atrial fibrillation.

Design outcomes

Primary

MeasureTime frame
Mitral Regurgitation;symptoms;physicial examination;ECG;6 mins hall walk - secondary indicator;Treadmill exercise test - secondary indicator;Blood test - secondary indicato;

Countries

China

Contacts

Public ContactDr. Alex Pui Wai LEE
alexpwlee@cuhk.edu.hk+852 2632-3140

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026